Format
Sort by
Items per page

Send to

Choose Destination

Best matches for complement c3 schizophrenia:

Search results

Items: 1 to 20 of 26

1.

Association Between Polymorphisms of the Complement 3 Gene and Schizophrenia in a Han Chinese Population.

Zhang S, Zhou N, Liu R, Rao W, Yang M, Cao B, Kang G, Kang Q, Zhu X, Li R, Yu Y, Yu Q.

Cell Physiol Biochem. 2018;46(6):2480-2486. doi: 10.1159/000489654. Epub 2018 May 5.

2.

Complement system biomarkers in first episode psychosis.

Kopczynska M, Zelek W, Touchard S, Gaughran F, Di Forti M, Mondelli V, Murray R, O'Donovan MC, Morgan BP.

Schizophr Res. 2017 Dec 23. pii: S0920-9964(17)30764-8. doi: 10.1016/j.schres.2017.12.012. [Epub ahead of print]

3.

Complement System in Neural Synapse Elimination in Development and Disease.

Presumey J, Bialas AR, Carroll MC.

Adv Immunol. 2017;135:53-79. doi: 10.1016/bs.ai.2017.06.004. Epub 2017 Jul 31. Review.

PMID:
28826529
4.

Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.

Ali FT, Abd El-Azeem EM, Hamed MA, Ali MAM, Abd Al-Kader NM, Hassan EA.

Schizophr Res. 2017 Oct;188:98-109. doi: 10.1016/j.schres.2017.01.016. Epub 2017 Jan 15.

PMID:
28100419
5.

Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia.

Li H, Zhang Q, Li N, Wang F, Xiang H, Zhang Z, Su Y, Huang Y, Zhang S, Zhao G, Zhou R, Mao L, Lin Z, Cai W, Fang Y, Xie B, Zhao M, Hong W.

Psychiatry Res. 2016 Dec 30;246:700-706. doi: 10.1016/j.psychres.2016.10.061. Epub 2016 Nov 2.

PMID:
27829509
6.

Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers.

Hong W, Zhao M, Li H, Peng F, Wang F, Li N, Xiang H, Su Y, Huang Y, Zhang S, Zhao G, Zhou R, Mao L, Lin Z, Fang Y, Zhang Q, Xie B.

Sci Rep. 2016 Jun 9;6:27584. doi: 10.1038/srep27584.

7.

Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis.

Zhang C, Zhang Y, Cai J, Chen M, Song L.

Pharmacogenomics J. 2017 Jan;17(1):92-97. doi: 10.1038/tpj.2015.68. Epub 2015 Oct 27.

PMID:
26503818
8.

A Preliminary Genetic Analysis of Complement 3 Gene and Schizophrenia.

Ni J, Hu S, Zhang J, Tang W, Lu W, Zhang C.

PLoS One. 2015 Aug 25;10(8):e0136372. doi: 10.1371/journal.pone.0136372. eCollection 2015.

9.

C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients.

Nsaiba MJ, Lapointe M, Mabrouk H, Douki W, Gaha L, Pérusse L, Bouchard C, Jrad BB, Cianflone K.

Neurochem Res. 2015 May;40(5):906-14. doi: 10.1007/s11064-015-1543-z. Epub 2015 Feb 27. Erratum in: Neurochem Res. 2016 Apr;41(4):944.

PMID:
25720829
10.

Complement factors in newly diagnosed Nigerian schizoprenic patients and those on antipsychotic therapy.

Idonije OB, Akinlade KS, Ihenyen O, Arinola OG.

Niger J Physiol Sci. 2012 Jun 7;27(1):19-21.

PMID:
23235303
11.

Deficiencies and excessive human complement system activation in disorders of multifarious etiology.

Tichaczek-Goska D.

Adv Clin Exp Med. 2012 Jan-Feb;21(1):105-14. Review.

12.

Increased serum levels of C3 and C4 in patients with schizophrenia compared to eutymic patients with bipolar disorder and healthy.

Santos Sória Ld, Moura Gubert Cd, Ceresér KM, Gama CS, Kapczinski F.

Rev Bras Psiquiatr. 2012 Mar;34(1):119-20. No abstract available.

13.

Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia.

Arakelyan A, Zakharyan R, Khoyetsyan A, Poghosyan D, Aroutiounian R, Mrazek F, Petrek M, Boyajyan A.

BMC Clin Pathol. 2011 Aug 25;11:10. doi: 10.1186/1472-6890-11-10.

14.

Altered MHC class I expression in dorsolateral prefrontal cortex of nonsmoker patients with schizophrenia.

Kano S, Nwulia E, Niwa M, Chen Y, Sawa A, Cascella N.

Neurosci Res. 2011 Nov;71(3):289-93. doi: 10.1016/j.neures.2011.07.1818. Epub 2011 Jul 27.

PMID:
21801761
15.

Alternative complement pathway in schizophrenia.

Boyajyan A, Khoyetsyan A, Chavushyan A.

Neurochem Res. 2010 Jun;35(6):894-8. doi: 10.1007/s11064-010-0126-2. Epub 2010 Jan 26.

PMID:
20101522
16.

The complement system in schizophrenia.

Mayilyan KR, Weinberger DR, Sim RB.

Drug News Perspect. 2008 May;21(4):200-10. doi: 10.1358/dnp.2008.21.4.1213349. Review.

17.

Cryoglobulins as indicators of upregulated immune response in schizophrenia.

Boyajyan A, Khoyetsyan A, Tsakanova G, Sim RB.

Clin Biochem. 2008 Apr;41(6):355-60. Epub 2007 Dec 4.

PMID:
18093542
18.

Classical pathway complement activity in schizophrenia.

Hakobyan S, Boyajyan A, Sim RB.

Neurosci Lett. 2005 Feb 1;374(1):35-7.

PMID:
15631892
19.

Increased levels of CD8+ and CD4+ 45RA+ lymphocytes in schizophrenic patients.

Cazzullo CL, Saresella M, Roda K, Calvo MG, Bertrando P, Doria S, Clerici M, Salvaggio A, Ferrante P.

Schizophr Res. 1998 May 4;31(1):49-55.

PMID:
9633836
20.

Acute phase proteins in male Chinese schizophrenic patients in Singapore.

Wong CT, Tsoi WF, Saha N.

Schizophr Res. 1996 Nov 15;22(2):165-71.

PMID:
8958601

Supplemental Content

Loading ...
Support Center